Aimmune Therapeutics is set to present new data on its AR101 compound, Palforzia, a potential new treatment for peanut allergies, in early November 2019…
A recent study examined the use of complementary and alternative medicine (CAM) to help women as they transition into menopause. These CAM therapies included…
Biogen announced that it will pursue the U.S. Food and Drug Administration (FDA)’s regulatory approval process for its drug aducanumab to treat Alzheimer’s disease.…
A recent study from Mayo Clinic reveals new insights for healthcare providers in understanding patients’ acceptable threshold in withstanding treatment burden. (more…)
A recent study from Mayo Clinic reveals new insights for healthcare providers in understanding patients’ acceptable threshold in withstanding treatment burden. (more…)